A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
Clinical trial NCT07608770 · RECRUITING
Trial details
- NCT number
- NCT07608770
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-04-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.